"A 10% reduction in assumed yield reduces biological assets by $52.3m, a 10% reduction in price assumed does something similar. As the Glaucus report has proved, QIN are nowhere near hitting their assumed yields and survivorship, whilst no one (who exists) has taken any significant volume at QIN's prices. This means that the value of those biological assets is highly questionable."
Price at time of posting: $1.21
Why didn't you listen to facts?
QIN Price at posting:
29.5¢ Sentiment: Sell Disclosure: Not Held